Evidence map›Paper›PMID 39991422›Full record

ArticleCureus2025

Diagnostic Accuracy of FDG PET-CT in Lymph Nodal Staging of Lung Cancer.

Iram Sagheer Khan, Saira Mashkoor, Seema Shafiq, Faiza Amber, Raima Kaleemi, Sadaf Nausheen, Pinkey Kumari, Atif A Hashmi

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Iram Sagheer KhanRadiology, United Medical and Dental College, Karachi, PAK.
Saira MashkoorRadiology, Altnagelvin Hospital, Galway, IRL.
Seema ShafiqRadiology, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Faiza AmberRadiology, Dow University of Health Sciences, Karachi, PAK.
Raima KaleemiNuclear Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Sadaf NausheenNuclear Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Pinkey KumariInternal Medicine, Hamdard College of Medicine and Dentistry, Karachi, PAK.
Atif A HashmiPathology, Liaquat National Hospital and Medical College, Karachi, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Lymph node staging is a critical component in managing lung cancer, as it determines prognosis and guides treatment decisions. Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) has emerged as a highly sensitive and specific imaging modality for evaluating nodal involvement, surpassing conventional imaging techniques. Therefore, this study evaluated the diagnostic accuracy of PET-CT in lymph nodal staging of lung cancer, using histopathology as the gold standard. Methodology This cross-sectional study was conducted at the Radiology and PET Scan Department, Jinnah Postgraduate Medical Centre (JPMC), Karachi, over six months, from January 28, 2021, to July 28, 2021, using a non-probability consecutive sampling. It included 127 biopsy-proven lung cancer patients aged 21-80 years. FDG PET-CT scans were evaluated by an experienced radiologist, with findings compared against histopathology results after surgery and biopsy. Using IBM SPSS Statistics for Windows, Version 22 (Released 2013; IBM Corp., Armonk, New York, United States), data analysis included calculating the sensitivity, specificity, and predictive values of FDG PET-CT for nodal metastasis, with histopathology as the gold standard. Results The study findings showed that out of 127 lung cancer patients, with a mean age of 54.14 ± 10.41 years, 99 (78.0%) were male, and 111 (87.4%) were aged >40 years. Symptoms persisted for a mean of 12.04 ± 6.82 weeks, and 88 (69.30%) had standardized uptake value (SUV)>3.0. Nodal staging showed N1 nodes in 64 (50.40%), N2 in 37 (29.10%), and N3 in 26 (20.50%). PET-CT detected nodal metastasis in 89 (70.18%) of cases, with histopathology confirming metastasis in 95 (74.88%). PET-CT achieved a sensitivity of 91.50%, specificity of 93.75%, positive predictive value (PPV) of 97.75%, and negative predictive value (NPV) of 78.95%. The overall accuracy of PET-CT was 92.13%, with a strong correlation to histopathology, emphasizing its reliability in staging nodal metastasis. Conclusion This study concluded the high diagnostic accuracy of PET-CT in detecting nodal metastasis in lung cancer, with an overall accuracy of 92.13%. PET-CT demonstrated excellent sensitivity (91.50%) and specificity (93.75%). These results confirm PET-CT as a reliable imaging modality for lymph nodal staging.

Indexed as

computed tomographydiagnostic accuracylung cancerlymph nodal stagingpositron emission tomography

Identifiers

PMID39991422
PMCPMC11846659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.